Latest Insights on COVID-19

Patients with Coronavirus disease 2019 or COVID-19 have coagulopathy and are at a high risk of thrombosis and death.³⁹

A prophylactic dose of low-molecular–weight heparin is recommended as per the American Society of Hematology guidelines.^40,41

Ongoing studies can test strategies to guide school reopening, on-site testing, treatment for influenza in homeless centers, household transmission studies, and community-based vaccine effectiveness study (ASH 2020).

Bio-specimen repositories linked with clinical data are essential for real-time identification of novel pathogens (ASH 2020).

Community-based studies provide an opportunity to identify pathogens early and take steps to prevent further transmission (ASH 2020).